PharmaShots | Incisive News in 3 Shots

Subscribe Now

RegulatoryTreatment

Vanda's Hetlioz (tasimelteon) Receives the US FDA's Approval for Nighttime Sleep Disturbances in Smith-Magenis Syndrome

Vanda's Hetlioz (tasimelteon) Receives the US FDA's Approval for Nighttime Sleep Disturbances in Smith-Magenis Syndrome

December 1, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us